Vitro Diagnostics Inc. (fka VODG)

[Potse]

Shuster...comments/statements on VODG's media.....

Neuromics CEO Pete Shuster has made a couple of interesting comments/statements about VODG's media (MSC-Gro) in some of his posts on LinkedIn forums during the last couple of weeks or so. It sounds like Neuromics/VODG are now actively involved with some foreign entities in the area of hMSC expansion.

He provides links to that 4/30/2013 slideshare presentation on Biopharma musculoskeletal disorders in each of the posts, so there is no mistaking that he is directly referring to Vitro Biopharma's media product. I have placed in bold a couple of things that caught my attention......

1) Optimizing Expansion of Autologously Derived hMSCs

We are working with several non US orgs that are expanding fat derived Stem Cells for treatment of Musculoskeletal Disorders. The theory is better media=more hMSCs; more MSCs=better therapeutic outcomes. Do you agree? Is anyone out there expanding hMSCs prior to treatment? How many cells do you think are optimal? Do you think the regs are too restrictive in the US re expansion of autologously derived stem cells?
http://www.linkedin.com/groupItem?view=&gid=4117443&type=member&item=239799900&commentID=137244805#commentID_137244805

2) Great David. Clinics in countries (like Australia) that have a regulatory climate that allow expansion of autologous or allogeneic MSCs for therapies have found our media to lower costs=more cells in less time: www.slideshare.net/pshuster1/biopharma-musculoskeletal-disorders4302013-20475556 . If you have interest, let me know.

http://www.linkedin.com/groupItem?view=&gid=4117443&type=member&item=241091903&commentID=138438666#commentID_138438666